Terms: = Breast cancer AND RALGDS, FLJ20922, 5900, ENSG00000160271, RalGEF, RGF, Q12967 AND Treatment
4 results:
1. Transformation of MCF-10A cells by random mutagenesis with frameshift mutagen ICR191: a model for identifying candidate breast-tumor suppressors.
Zientek-Targosz H; Kunnev D; Hawthorn L; Venkov M; Matsui S; Cheney RT; Ionov Y
Mol Cancer; 2008 Jun; 7():51. PubMed ID: 18534021
[TBL] [Abstract] [Full Text] [Related]
2. Cost-effectiveness analysis of exemestane compared with megestrol in patients with advanced breast carcinoma.
Hillner BE; Radice D
Cancer; 2001 Feb; 91(3):484-9. PubMed ID: 11169930
[TBL] [Abstract] [Full Text] [Related]
3. Strontium-89 chloride (Metastron) for palliative treatment of bony metastases. The University of Minnesota experience.
Lee CK; Aeppli DM; Unger J; Boudreau RJ; Levitt SH
Am J Clin Oncol; 1996 Apr; 19(2):102-7. PubMed ID: 8610630
[TBL] [Abstract] [Full Text] [Related]
4. Conservative surgery and radiation therapy for intraductal carcinoma of the breast.
Lewin AA; Cohen A; Abitbol AA; Schwade JG; Osman D; DerHagopian R; Ostroski J; Marcial-Vega V; Houdek P; Gould E
J Fla Med Assoc; 1992 Nov; 79(11):762-5. PubMed ID: 1336028
[TBL] [Abstract] [Full Text] [Related]
